Literature DB >> 8550823

Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.

R Taylor1, I Magnusson, D L Rothman, G W Cline, A Caumo, C Cobelli, G I Shulman.   

Abstract

Despite extensive recent studies, understanding of the normal postprandial processes underlying immediate storage of substrate and maintenance of glucose homeostasis in humans after a mixed meal has been incomplete. The present study applied 13C nuclear magnetic resonance spectroscopy to measure sequential changes in hepatic glycogen concentration, a novel tracer approach to measure postprandial suppression of hepatic glucose output, and acetaminophen to trace the pathways of hepatic glycogen synthesis to elucidate the homeostatic adaptation to the fed state in healthy human subjects. After the liquid mixed meal, liver glycogen concentration rose from 207 +/- 22 to 316 +/- 19 mmol/liter at an average rate of 0.34 mmol/liter per min and peaked at 318 +/- 31 min, falling rapidly thereafter (0.26 mmol/liter per min). The mean increment at peak represented net glycogen synthesis of 28.3 +/- 3.7 g (approximately 19% of meal carbohydrate content). The contribution of the direct pathway to overall glycogen synthesis was 46 +/- 5 and 68 +/- 8% between 2 and 4 and 4 and 6 h, respectively. Hepatic glucose output was completely suppressed within 30 min of the meal. It increased steadily from 60 to 255 min from 0.31 +/- 32 to 0.49 +/- 18 mg/kg per min then rapidly returned towards basal levels (1.90 +/- 0.04 mg/kg per min). This pattern of change mirrored precisely the plasma glucagon/insulin ratio. These data provide for the first time a comprehensive picture of normal carbohydrate metabolism in humans after ingestion of a mixed meal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550823      PMCID: PMC507070          DOI: 10.1172/JCI118379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man.

Authors:  J Radziuk; R Inculet
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

2.  Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes.

Authors:  D T Finegood; R N Bergman
Journal:  Am J Physiol       Date:  1983-05

3.  Splanchnic and peripheral disposal of oral glucose in man.

Authors:  L D Katz; M G Glickman; S Rapoport; E Ferrannini; R A DeFronzo
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

4.  Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans.

Authors:  G I Shulman; G Cline; W C Schumann; V Chandramouli; K Kumaran; B R Landau
Journal:  Am J Physiol       Date:  1990-09

5.  Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

Authors:  A Mitrakou; D Kelley; T Veneman; T Jenssen; T Pangburn; J Reilly; J Gerich
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

6.  Glycogen synthesis by rat hepatocytes.

Authors:  J Katz; S Golden; P A Wals
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

7.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

Authors:  C Bogardus; S Lillioja; K Stone; D Mott
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man.

Authors:  W K Waldhäusl; S Gasić; P Bratusch-Marrain; P Nowotny
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

9.  Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.

Authors:  T Ishida; Z Chap; J Chou; R Lewis; C Hartley; M Entman; J B Field
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

Authors:  R A DeFronzo; D Simonson; E Ferrannini
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

View more
  53 in total

1.  Tissue glycogen content and glucose intolerance.

Authors:  Masato Kasuga; Wataru Ogawa; Takeshi Ohara
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  The use of magnetic resonance methods in translational cardiovascular research.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  J Cardiovasc Transl Res       Date:  2009-01-13       Impact factor: 4.132

Review 3.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

4.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 5.  A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?

Authors:  Gaurav Chikara; Pramod Kumar Sharma; Pradeep Dwivedi; Jaykaran Charan; Sneha Ambwani; Surjit Singh
Journal:  Indian J Clin Biochem       Date:  2017-06-08

Review 6.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

Review 7.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

8.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

9.  Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.

Authors:  C Robb Flynn; Vance L Albaugh; Robyn A Tamboli; Justin M Gregory; Amma Bosompem; Reem M Sidani; Jason J Winnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

Review 10.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.